Training the Global Ready Scholar

培训全球就绪学者

• 批准号: 7467577
• 负责人: CHRISTOS COUTIFARIS
• 金额: $ 9.55万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-29 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7467577
• 关键词: Address; American; Area; Biocompatible Materials; Bioethics; Biological Preservation; Biomechanics; Breeding; Cancer Patient; Cancer Survivor; Caring; Cellular biology; Censuses; Certification; Cessation of life; Clinical; Clinical Research; Cognitive; Communication; Complication; Development; Discipline; Discipline of obstetrics; Disease; Early Diagnosis; Education; Emerging Technologies; Endocrinologist; Environment; Fellowship; Fellowship Program; Female; Fertility; Foundations; Funding; Generations; Goals; Gonadal structure; Growth; Gynecology; Health; Home environment; Human; Impairment; Infertility; Institution; Interdisciplinary Study; International; Laws; Lead; Learning; Life; Malignant Neoplasms; Mathematics; Medical; Medical Oncology; Medicine; Mentors; Molecular; National Research Service Awards; Nature; Numbers; Oocytes; Ovary; Patients; Pediatric Oncology; Physicians; Physiology; Policy Research; Population; Process; Purpose; Quality of life; Radiation; Rate; Religion; Reproductive Endocrinology; Reproductive Health; Reproductive Medicine; Research; Research Personnel; Research Training; Residencies; Science; Scientist; Social Sciences; Specialist; Spontaneous abortion; Structure; Survivors; Technology; Time; Tissue Engineering; Toxic effect; Training; Training Programs; Training and Education; Translations; Uncertainty; United States National Institutes of Health; Uterus; Woman; Women' s Health; base; cancer therapy; career; chemotherapy; coping; cryobiology; experience; implantation; interest; multidisciplinary; nonhuman primate; novel; professor; programs; reproductive; success

In recent years, cancer has been converted, in many cases, from a death sentence to a disease of many survivors. Aggressive cancer treatments take a significant toll on patient's quality of life. A recognized complication for women after chemotherapy or radiation is the toxicity to the ovaries, which results in the damage or loss of oocytes leading to impairment or loss of fertility. The purpose of the Oncofertility Consortium is to attack the fertility threat posed by cancer treatment by training a globally ready workforce with the expertise to manage the reproductive needs of the woman with cancer. The impact of such a program in the general field of Women's Health can be tremendous for generating a multidisciplinary force of doctors for coping with fertility concerns. The long-term success of the oncofertility discipline requires the well orchestrated and focused development of a physician-scientist global workforce, which will implement the research and clinical agenda and ultimately be the origin for the expansion and development of this new, interdisciplinary field of oncofertility. It is the intent of this T90/R90 proposal to train and educate the first generation of oncofertility specialists in research directly related to the reproductive needs of the cancer patient and survivor. Such education and training programs will provide the foundations for the further development of this discipline that is at the intersection of oncology, pediatrics, reproductive science and medicine, biomechanics, material science, mathematics, social science, bioethics, religion, policy research, reproductive health law and cognitive and learning science. Given the clinical and research training fellows receive, the executive committee of this training and educational program believes that the first generation of oncofertility specialists should be bred from within the ranks of Reproductive Endocrinology and Infertility (REI), which is one of four subspecialty fellowships for advanced training after completion of a residency in Obstetrics and Gynecology. Formal certification for this advanced training in Reproductive Medicine is under the aegis of the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology, Inc. (ABOG). Research is a central feature of fellowship programs and, therefore, the proposed oncofertility training program dovetails perfectly with the clinical and educational objectives in reproductive endocrinology. The proposed National and International Training Program in Oncofertility will be the ONLY federally supported mechanism for research training of fellows critical for entry into the pipeline of academic oncofertility specialists.

近年来，在许多情况下，癌症已经从死刑判决转变为许多人的疾病。 幸存者积极的癌症治疗对患者的生活质量造成了重大影响。公认的 化疗或放疗后女性的并发症是卵巢毒性，这导致 卵母细胞的损伤或损失导致生育能力的损害或丧失。肿瘤生育的目的 联盟将通过培训全球准备就绪的劳动力来应对癌症治疗带来的生育威胁 有专业知识来管理癌症妇女的生殖需求。这种影响 在妇女健康的一般领域的计划可以产生一个多学科的巨大 医生应对生育问题的力量。肿瘤生育学科的长期成功 需要精心策划和集中发展全球医生-科学家队伍， 实施研究和临床议程，并最终成为扩展和发展的起源 这一新的跨学科领域的研究成果。本T90/R90提案旨在培训和教育 第一代肿瘤生育专家的研究直接关系到生殖的需要， 癌症患者和幸存者。这些教育和培训方案将为进一步的 这一学科的发展是在肿瘤学，儿科学，生殖科学和 医学、生物力学、材料科学、数学、社会科学、生物伦理学、宗教、政策研究、 生殖健康法以及认知和学习科学。鉴于临床和研究培训研究员 接受，这个培训和教育计划的执行委员会认为，第一代 肿瘤生育专家应从生殖内分泌学和不孕不育领域培养 (REI)，这是四个亚专业奖学金的高级培训后，完成居住在 妇产科。生殖医学高级培训的正式认证正在进行中。 美国产科委员会生殖内分泌学和不孕症部的支持 妇科公司Gynecology，Inc.（ABOG）。研究是奖学金计划的核心特征，因此， 建议的肿瘤生育培训计划完全符合临床和教育目标， 生殖内分泌学拟议的国家和国际肿瘤生育培训计划将 唯一的联邦支持的研究员研究培训机制，对进入管道至关重要， 学术肿瘤生育专家。